Seeking Alpha
 

Kimberly-Clark Corporation (KMB)

- NYSE
  • Apr. 2, 2013, 12:47 PM
    Kimberly-Clark (KMB +1.7%) moves up after saying it's acquired the anesthesia business of Life-Tech, a Texas-based medical device manufacturer. The acquisition consists of needles, catheters and accessories associated with peripheral nerve block procedures, and the assets will become part of KMB's Health Care business and added to K-C Health Care's ON-Q family of products.
    | Comment!
  • May 10, 2012, 11:39 AM
    Kimberly Clark (KMB) is among the tentative bidders for German bandages maker BSN Medical, which is being sold by P-E firm Montagu, Reuters reports. Kimberly's competition includes rival ConvaTec as well as P-E companies EQT and Permira, with offers ranging from €1.6B-€1.8B ($2.1B-$2.3B).
    | Comment!
  • Jul. 15, 2011, 4:50 PM
    Chris Stuart questions whether Clorox (CLX +8.9%) is really worth $100/share, as Carl Icahn claims it would be to a potential acquirer such PGUL, CL, or KMB. At $100, Clorox, which recently forecast FY2012 growth of just 1-3%, would trade at nearly 25x its estimated FY2012 EPS.
    | 1 Comment
  • Jul. 15, 2011, 6:25 AM
    Icahn notes Clorox (CLX) "will not come close" to meeting sales growth forecasts of 3-5%/year. His offer is an attempt to prod CLX to pursue a deal with a "strategic buyer" (PG, UN, CL, KMB, Reckitt Benckiser, Henkel) - who Icahn believes will pay a higher price. "Quite simply, there are few strategic opportunities like Clorox."
    | 1 Comment
Visit Seeking Alpha's
KMB vs. ETF Alternatives
Company Description
Kimberly-Clark Corp is engaged in the manufacturing and marketing of a products made from natural or synthetic fibers using technologies in fibers, nonwovens and absorbency.